Accelerating the development of biomarkers for drug safety workshop summary
"Biomarkers can be defined as indicators of any biologic state, and they are central to the future of medicine. As the cost of developing drugs has risen in recent years, reducing the number of new drugs approved for use, biomarker development may be a way to cut costs, enhance safety, and prov...
| Main Author: | |
|---|---|
| Corporate Author: | |
| Other Authors: | , |
| Format: | eBook |
| Language: | English |
| Published: |
Washington, D.C.
National Academies Press
c2009, 2009
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Overview Of key issues
- Cardiac safety biomarkers
- Assessing and predicting kidney safety
- Biomarkers of acute idiosyncratic hepatocellular injury in clinical trials
- Future considerations
- Includes bibliographical references (p. 55-57)